Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Barrett Esophagus 13Stomach Neoplasms 8Adenocarcinoma Of Esophagus 6Gastroesophageal Reflux 4Gastritis, Atrophic 4Gastrointestinal Neoplasms 2Esophageal Neoplasms 2Carcinoma, Hepatocellular 2Adenomatous Polyposis Coli 2Weight Loss 1Thrombocythemia, Essential 1Stomach Ulcer 1Primary Myelofibrosis 1Precancerous Conditions 1Polycythemia Vera 1Pancreatic Neoplasms 1Neoplasms 1Myeloproliferative Disorders 1Lymphoma, Mantle-Cell 1Gastrointestinal Hemorrhage 1Gastrointestinal Diseases 1Gastritis 1Fibrosis 1Esophagitis 1Esophageal Squamous Cell Carcinoma 1Duodenal Neoplasms 1Deglutition Disorders 1Colorectal Neoplasms 1Cholangiocarcinoma 1Adenocarcinoma of the Esophagogastric Junction 1

Interventions

Gemcitabine 112Cisplatin 76Oxaliplatin 45pembrolizumab 35Fluorouracil 32Capecitabine 31lenvatinib 26durvalumab 26Leucovorin 26Magnetic Resonance Spectroscopy 14Irinotecan 13Drug Therapy 13Nivolumab 12Biopsy 12Albumin-Bound Paclitaxel 12Specimen Handling 11Radiofrequency Ablation 11130-nm albumin-bound paclitaxel 11tislelizumab 10pemigatinib 10apatinib 10Taxes 10Radiotherapy 10Floxuridine 10Folfox protocol 9Bevacizumab 9S 1 (combination) 8Photochemotherapy 8Liver Transplantation 8Cholangiopancreatography, Endoscopic Retrograde 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cholangiocarcinoma × Endoscopy, Digestive System × Clear all
NCT03942328 2026-04-20

Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer

Mayo Clinic

Phase 1/2 Recruiting
85 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡